METHOD OF ACOUSTIC SHOCK WAVE TREATMENTS FOR COMPLICATIONS ASSOCIATED WITH SURGICAL MESH IMPLANTS

• US 20140330174A1
• Filed: 05/01/2013
• Published: 11/06/2014
• Est. Priority Date: 05/01/2013
• Status: Abandoned Application

• Current Assignee: General Patent, LLC (Tissue Regeneration Technologies LLC)
• Original Assignee: General Patent, LLC (Tissue Regeneration Technologies LLC)
• Inventors: Warlick, John, Schaden, Wolfgang
• Application Number:
  US13/874,729
• Publication Number:
  US 20140330174A1
• Time in Patent Office: Days
• US Class Current: 601/2
• CPC Class Codes: A61B 2018/00559 Female reproductive organs
• CPC Class Codes: A61N 7/00 Ultrasound therapy lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 ; using ultrasound for introducing media into the body A61M37/0092

Abstract

The method of treatment for vaginal tissue inflamed or damaged by complications from the use of a surgical mesh implant in the vagina of a patient is disclosed. The treatment has the steps of activating an acoustic shock wave generator or source to emit acoustic shock waves; and subjecting the vaginal tissue, pelvic region or the entire pelvic cavity region of the body to the acoustic shock waves stimulating said tissue wherein the tissue is positioned within a path of the emitted shock waves. The emitted shock waves can be convergent, divergent, planar or near planar.

Claims

1. A method of treatment for vaginal tissue inflamed or damaged by complications from the use of a surgical mesh implant in the vagina of a patient comprises the steps of:

activating an acoustic shock wave generator or source to emit acoustic shock waves; and

subjecting the vaginal tissue, or pelvic region of the body to the acoustic shock waves stimulating said tissue, wherein the tissue is positioned within a path of the emitted shock waves.

2. The method of treatment of claim 1 wherein the emitted shock waves are convergent, divergent, planar or near planar.

3. The method of treatment of claim 1 wherein the emitted shock waves are convergent having one or more geometric focal volumes of points at a distance of at least X from the generator or source, the method further comprising positioning the organ at a distance at or less than the distance X from the source.

4. The method of treatment of claim 1 further comprises the step of:

administering one or more medicaments prior, during or after subjecting the patient to acoustic shock waves.

5. The method of treatment of claim 1 further comprises the step of:

subjecting a tissue or organ to a surgical procedure to remove or repair some or all of any defects or degenerative tissues.

6. The method of treatment of claim 1 wherein the patient has an indication of one or more pathological conditions including:

mesh erosion, mesh extrusion, pain, inflammation, organ perforation, incontinence, constipation, vaginal shortening, vaginal tightening, infection or infertility or impotency.

7. A method of stimulation for vaginal tissue inflamed or damaged by the use of a surgical mesh implant in the vagina of a patient comprising the steps of:

activating an acoustic shock wave generator or source to emit pressure pulses including but not limited to very fast pressure pulses called acoustic shock waves directed toward the vaginal tissue or pelvic region to impinge the vaginal tissue or pelvic region with pressure pulses or shock waves having a low energy density in the range of 0.000001 mJ/mm² to 1.0 mJ/mm²;

the pressure pulse being an acoustic pulse which includes several cycles of positive and negative pressure, wherein the pressure pulse has an amplitude of the positive part of such a cycle above 0.1 MPa and the time duration of the pressure pulse cycle is from a microsecond to about a second, rise times to the peak pressure of the positive part of the first pressure cycle being in the range of nano-seconds (ns) up to milli-seconds (ms), the acoustic shock waves being very fast pressure pulses having amplitudes of the positive part of the cycle similarly above 0.1 MPa but with rise times to a peak positive pressure of the positive part of the amplitude being below 100 ns, the duration of the shock wave is below 3 micro-seconds (μ

s) for the positive part of a cycle and above 3 micro-seconds for the negative part of a cycle;

subjecting the vaginal tissue or pelvic region of the body to the convergent, divergent, planar or near planar acoustic shock waves or pressure pulses in the absence of a focal point impinging the vaginal tissue or pelvic region stimulating a cellular response in the absence of cellular damage evidenced by not experiencing the sensation of cellular hemorrhaging caused by the emitted waves or pulses in the vaginal tissue or pelvic region wherein the vaginal tissue or pelvic region is positioned within a path of the emitted shock waves or pressure pulses and away from any localized geometric focal volume or point of the emitted shock waves wherein the emitted shock waves or pressure pulses either have no geometric focal volume or point or have a focal volume or point ahead of the vaginal tissue or pelvic region or beyond the vaginal tissue or pelvic region thereby passing the emitted waves through the vaginal tissue or pelvic region while avoiding having any localized focal point within the vaginal tissue or pelvic region wherein the emitted pressure pulses or shock waves are convergent, divergent, planar or near planar and the pressure pulse shockwave generator or source is based on electro-hydraulic, electromagnetic, piezoceramic or ballistic wave generation having an energy density value ranging as low as 0.00001 mJ/mm2 to a high end of below 1.0 mJ/mm2; and

stimulating said vaginal tissue or pelvic region wherein the tissue or region is positioned within a path of the emitted shock waves removed from any focal point of the emitted acoustic shock wave.

8. The method of stimulation of claim 7 wherein the emitted shock waves are convergent having one or more geometric focal points at a distance of at least X from the generator or source, the method further comprising positioning the vaginal tissue or pelvic region at a distance less than the distance X from the source to position the one or more focal points beyond the treatment site of the vaginal tissue or pelvic region.

9. The method of stimulation of claim 7 further comprising the step of:

administering one or more medicaments prior, during or after subjecting the patient to acoustic shock waves.

10. The method of stimulation of claim 7 further comprising the step of:

testing the oocyte viability or count of the female infertility or impotence diagnosed patient after one or more acoustic shock wave stimulations.

11. The method of stimulation of claim 7 further comprising the step of:

subjecting a vaginal tissue or pelvic region to a surgical procedure to remove or repair some or all of any defects or degenerative damaged tissue.

12. The method of stimulation of claim 7 wherein the stimulated vaginal tissue or pelvic region has an indication of one or more pathological conditions including:

mesh erosion, mesh extrusion, pain, inflammation, organ perforation, incontinence, constipation, vaginal shortening, vaginal tightening, infection or infertility or impotency.

13. The method of stimulation of claim 7 where the emitted shock waves have an energy density of less than 0.2 mJ/mm2.

14. The method of stimulation of claim 7 where the emitted shock waves have an energy density in the range of 0.00001 to 0.1 mJ/mm2.